药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Hexachlorophene
Perhexiline
The metabolism of Chlorpheniramine can be decreased when combined with Perhexiline.
Hexachlorophene
Fusidic acid
The metabolism of Chlorpheniramine can be decreased when combined with Fusidic acid.
Hexachlorophene
Vilazodone
The metabolism of Vilazodone can be decreased when combined with Chlorpheniramine.
Hexachlorophene
Lumefantrine
The metabolism of Lumefantrine can be decreased when combined with Chlorpheniramine.
Hexachlorophene
Nilotinib
The metabolism of Nilotinib can be decreased when combined with Chlorpheniramine.
Hexachlorophene
Ritanserin
The metabolism of Ritanserin can be decreased when combined with Chlorpheniramine.
Hexachlorophene
Relugolix
The risk or severity of QTc prolongation can be increased when Relugolix is combined with Chlorpheniramine.
Hexachlorophene
Fostemsavir
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Chlorpheniramine.
Hexachlorophene
Lopinavir
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Chlorpheniramine.
Hexachlorophene
Ebastine
The risk or severity of QTc prolongation can be increased when Ebastine is combined with Chlorpheniramine.
Hexachlorophene
Lurasidone
The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Chlorpheniramine.
Hexachlorophene
Digitoxin
The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Chlorpheniramine.
Hexachlorophene
Posaconazole
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Chlorpheniramine.
Hexachlorophene
Inotersen
The risk or severity of QTc prolongation can be increased when Inotersen is combined with Chlorpheniramine.
Hexachlorophene
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Chlorpheniramine.
Hexachlorophene
Rufloxacin
The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Chlorpheniramine.
Hexachlorophene
Lidoflazine
The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Chlorpheniramine.
Hexachlorophene
Piromidic acid
The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Chlorpheniramine.
Hexachlorophene
Acetyldigoxin
The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Chlorpheniramine.
Hexachlorophene
Lorajmine
The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Chlorpheniramine.